Common side effects include nausea, constipation, and fatigue
After 40 weeks, all three doses of Tirzepatide demonstrated superior HbA1c and body weight reductions compared to placebo
Phase 2 trials test a drug on a few hundred participants over a year or so to establish efficacy and identify side effects
The cutting-edge weight loss injection is available at Skin101 Clinics
Corticosteroid as monotherapy depigmenting agents have demonstrated limited effectiveness and also could induce potential adverse reactions including epidermal atrophy, telangiectasia, acne, rosacea-like erythema, and perioral dermatitis (Menter, 2004)
When they interact, GLP-1 (or tirzepatide, in this case) unlocks and activates GLP-1 receptors